Diseases & Conditions >
This topic is from The 5-Minute Clinical Consult About our sources

Leukemia, Chronic Myelogenous Updated 4/2011

Email       Print Section  |  Print Topic       Add to My Favorites

BASICS

  • Description
  • Epidemiology
  • Risk Factors
  • General Prevention
  • Pathophysiology

DIAGNOSIS

  • Signs and Symptoms
  • Tests
  • Differential Diagnosis

TREATMENT

  • Medication (Drugs)
  • Additional Treatment
  • Surgery
  • In-patient Considerations

Ongoing Care

  • Follow-Up Recommendations
  • Prognosis
  • Complications
The following is an excerpt....
BASICS

Description
  • Chronic myelogenous leukemia (CML) is a myeloproliferative disorder characterized by clonal proliferation of myeloid precursors in the bone marrow with continuing differentiation into mature granulocytes.
  • Hallmark of CML is Philadelphia chromosome [translocation t(9;22)]
  • Natural history of the disease evolves in 3 clinical phases: A chronic phase, an accelerated phase, and blast phase or crisis (transformation to acute leukemia)
Epidemiology

Incidence
  • 1.6 cases/100,000 persons per year
  • Predominant age: 50–60 years
  • Predominant sex: Male > Female (1.3:1)
Prevalence

Accounts for 15–20% of adult leukemias

Risk Factors

Ionizing radiation exposure (uncommon)

Genetics

Acquired genomic changes

General Prevention

None currently identified

Pathophysiology

Philadelphia chromosome is a balanced translocation between BCR (on chromosome 22) and ...

You must be logged in to fully access this content.

Sign In
Sign up for a 30-Day Free Trial

Sign up for a 30-Day FREE Trial now and receive access to all content.

Start free trial!

Have a book code?

Submit your book code to create your FREE standard account.
See Also
Images >
Wright-Giemsa stain: chronic myelocytic leukemia (CML) with leukocytosis; 250xCredit: NA
Procedures & PT >